Gregory Edison Hunter - Net Worth and Insider Trading

Gregory Edison Hunter Net Worth

The estimated net worth of Gregory Edison Hunter is at least $40,306 dollars as of 2024-11-13. Gregory Edison Hunter is the Senior Officer of MediPharm Labs Corp and owns about 537,417 shares of MediPharm Labs Corp (TSX:LABS) stock worth over $40,306. Details can be seen in Gregory Edison Hunter's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gregory Edison Hunter has not made any transactions after 2023-06-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Gregory Edison Hunter

Gregory Edison Hunter Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gregory Edison Hunter owns 1 companies in total, including MediPharm Labs Corp (TSX:LABS) .

Click here to see the complete history of Gregory Edison Hunter’s form 4 insider trades.

Insider Ownership Summary of Gregory Edison Hunter

Ticker	Comapny	Transaction Date	Type of Owner
TSX:LABS	MediPharm Labs Corp	2023-06-22	Senior Officer

Gregory Edison Hunter Latest Holdings Summary

Gregory Edison Hunter currently owns a total of 1 stock. Gregory Edison Hunter owns 537,417 shares of MediPharm Labs Corp (TSX:LABS) as of June 22, 2023, with a value of $40,306.

Latest Holdings of Gregory Edison Hunter

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TSX:LABS	MediPharm Labs Corp	2023-06-22	537,417	0.08	40,306

Holding Weightings of Gregory Edison Hunter

Gregory Edison Hunter Form 4 Trading Tracker

According to the SEC Form 4 filings, Gregory Edison Hunter has made a total of 3 transactions in MediPharm Labs Corp (TSX:LABS) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in MediPharm Labs Corp is the sale of 211,257 shares on June 22, 2023, which brought Gregory Edison Hunter around $12,675.

Insider Trading History of Gregory Edison Hunter

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gregory Edison Hunter Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gregory Edison Hunter Ownership Network

Ownership Network List of Gregory Edison Hunter

No Data

Ownership Network Relation of Gregory Edison Hunter

Gregory Edison Hunter Owned Company Details

What does MediPharm Labs Corp do?

Who are the key executives at MediPharm Labs Corp?

Gregory Edison Hunter is the Senior Officer of MediPharm Labs Corp. Other key executives at MediPharm Labs Corp include Director & Senior Officer David Pidduck , Director & Senior Officer Bryan Howcroft , and Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6) Warren Everitt .

MediPharm Labs Corp (TSX:LABS) Insider Trades Summary

Over the past 18 months, Gregory Edison Hunter made 1 insider transaction in MediPharm Labs Corp (TSX:LABS) with a net sale of 211,257. Other recent insider transactions involving MediPharm Labs Corp (TSX:LABS) include a net sale of 399,773 shares made by Keith Strachan , a net sale of 2,031,162 shares made by David Pidduck ,

In summary, during the past 3 months, insiders sold 0 shares of MediPharm Labs Corp (TSX:LABS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,642,192 shares of MediPharm Labs Corp (TSX:LABS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,642,192 shares.

MediPharm Labs Corp (TSX:LABS)'s detailed insider trading history can be found in Insider Trading Tracker table.

MediPharm Labs Corp Insider Transactions

No Available Data

Gregory Edison Hunter Mailing Address

Above is the net worth, insider trading, and ownership report for Gregory Edison Hunter. Currently GuruFocus does not have mailing address information for Gregory Edison Hunter.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.